The global pulmonary drug delivery devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of respiratory diseases and growing awareness about the benefits of pulmonary drug delivery devices. The dry powder inhaler segment accounted for the largest share in the global pulmonary drug delivery devices market in 2018, followed by metered dose inhalers and nebulizers. The dry powder inhaler segment is expected to maintain its dominance throughout the forecast period due to its ease of use and low cost.
- The increasing prevalence of chronic respiratory diseases such as asthma and COPD is driving the growth of the Pulmonary Drug Delivery Devices market.
- Increasing awareness about pulmonary drug delivery devices among physicians and patients is also driving the growth of the Pulmonary Drug Delivery Devices market.
- The introduction of new products in this segment by major players such as Abbott, Medtronic, and Philips Healthcare are also driving the growth of this market.
- Increasing government funding for research on pulmonary drug delivery devices.
Industry Growth Insights published a new data on “Pulmonary Drug Delivery Devices Market”. The research report is titled “Pulmonary Drug Delivery Devices Market research by Types (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), By Applications (Asthma, COPD, Cystic Fibrosis, Other), By Players/Companies Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb, Mylan N.V, Omron Corp, F. Hoffmann-La Roche, 3M Healthcare, Sunovion Pharmaceuticals, Koninklijke Philips N.V, Gerresheimer AG, Bespak, AptarGroup, SHL Group, Nypro Healthcare, Hovione, Chiesi Farmaceutici S.P.A”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pulmonary Drug Delivery Devices Market Research Report
By Type
Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer
By Application
Asthma, COPD, Cystic Fibrosis, Other
By Companies
Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb, Mylan N.V, Omron Corp, F. Hoffmann-La Roche, 3M Healthcare, Sunovion Pharmaceuticals, Koninklijke Philips N.V, Gerresheimer AG, Bespak, AptarGroup, SHL Group, Nypro Healthcare, Hovione, Chiesi Farmaceutici S.P.A
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Pulmonary Drug Delivery Devices Market Report Segments:
The global Pulmonary Drug Delivery Devices market is segmented on the basis of:
Types
Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, COPD, Cystic Fibrosis, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim GmbH
- Novartis AG
- GlaxoSmithKline
- AstraZeneca
- Teva Pharmaceutical Industries
- Merck
- MannKind
- Bristol-Myers Squibb
- Mylan N.V
- Omron Corp
- F. Hoffmann-La Roche
- 3M Healthcare
- Sunovion Pharmaceuticals
- Koninklijke Philips N.V
- Gerresheimer AG
- Bespak
- AptarGroup
- SHL Group
- Nypro Healthcare
- Hovione
- Chiesi Farmaceutici S.P.A
Highlights of The Pulmonary Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry Powder Inhaler
- Metered Dose Inhaler
- Nebulizer
- By Application:
- Asthma
- COPD
- Cystic Fibrosis
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pulmonary Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pulmonary drug delivery devices are medical devices that are inserted into the airway of a patient to deliver medications directly to the lungs. Pulmonary drug delivery devices can be used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
Some of the key players operating in the pulmonary drug delivery devices market are Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb, Mylan N.V, Omron Corp, F. Hoffmann-La Roche, 3M Healthcare, Sunovion Pharmaceuticals, Koninklijke Philips N.V, Gerresheimer AG, Bespak, AptarGroup, SHL Group, Nypro Healthcare, Hovione, Chiesi Farmaceutici S.P.A.
The pulmonary drug delivery devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pulmonary Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pulmonary Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pulmonary Drug Delivery Devices Market - Supply Chain
4.5. Global Pulmonary Drug Delivery Devices Market Forecast
4.5.1. Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pulmonary Drug Delivery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pulmonary Drug Delivery Devices Market Absolute $ Opportunity
5. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Type
5.3.1. Dry Powder Inhaler
5.3.2. Metered Dose Inhaler
5.3.3. Nebulizer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Application
6.3.1. Asthma
6.3.2. COPD
6.3.3. Cystic Fibrosis
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pulmonary Drug Delivery Devices Demand Share Forecast, 2019-2026
9. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Application
9.4.1. Asthma
9.4.2. COPD
9.4.3. Cystic Fibrosis
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Type
9.7.1. Dry Powder Inhaler
9.7.2. Metered Dose Inhaler
9.7.3. Nebulizer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pulmonary Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Application
10.4.1. Asthma
10.4.2. COPD
10.4.3. Cystic Fibrosis
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Type
10.7.1. Dry Powder Inhaler
10.7.2. Metered Dose Inhaler
10.7.3. Nebulizer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pulmonary Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Application
11.4.1. Asthma
11.4.2. COPD
11.4.3. Cystic Fibrosis
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Type
11.7.1. Dry Powder Inhaler
11.7.2. Metered Dose Inhaler
11.7.3. Nebulizer
11.. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pulmonary Drug Delivery Devices Demand Share, 2019-2026
12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Application
12.4.1. Asthma
12.4.2. COPD
12.4.3. Cystic Fibrosis
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Type
12.7.1. Dry Powder Inhaler
12.7.2. Metered Dose Inhaler
12.7.3. Nebulizer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pulmonary Drug Delivery Devices Demand Share, 2019-2026
13. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Application
13.4.1. Asthma
13.4.2. COPD
13.4.3. Cystic Fibrosis
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pulmonary Drug Delivery Devices Market Size and Volume Forecast by Type
13.7.1. Dry Powder Inhaler
13.7.2. Metered Dose Inhaler
13.7.3. Nebulizer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pulmonary Drug Delivery Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pulmonary Drug Delivery Devices Market: Market Share Analysis
14.2. Pulmonary Drug Delivery Devices Distributors and Customers
14.3. Pulmonary Drug Delivery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim GmbH
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AstraZeneca
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teva Pharmaceutical Industries
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MannKind
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bristol-Myers Squibb
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mylan N.V
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Omron Corp
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. F. Hoffmann-La Roche
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. 3M Healthcare
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sunovion Pharmaceuticals
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Koninklijke Philips N.V
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Gerresheimer AG
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Bespak
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. AptarGroup
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. SHL Group
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Nypro Healthcare
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Hovione
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook